Who owns Lundbeck?
Who owns Lundbeck?
Hans Lundbeck
Lundbeck
| Type | Aktieselskab |
|---|---|
| Founder | Hans Lundbeck |
| Headquarters | Copenhagen, Denmark |
| Key people | Deborah Dunsire (CEO) Lars Rasmussen (Chairman) Lene Skole (Vice Chairman) |
| Revenue | DKK 17.2 billion (2017) |
What drugs does Lundbeck make?
The products that are available in the United States from Lundbeck include: Abilify Maintena (aripiprazole) is an atypical antipsychotic medication used in the treatment of psychotic disorders and bipolar disorder. Carnexiv (carbamazepine) is an anticonvulsant medication.
Where is Lundbeck located?
Denmark
Global presence We are headquartered in Denmark and located in more than 50 countries around the world. We have production facilities in Denmark, France, and Italy, and research centers in Denmark and US. We have employees in more than 50 countries, and employ approximately 5,600 people across the value chain.
Is Lundbeck A good company?
Leading Pharmaceutical Company Lundbeck is an excellent company to be part of. They are dedicated to delivering CNS products to patients suffering from mental Illness. They are an excellent company.
How many employees does Lundbeck have?
4,9802017
Lundbeck/Number of employees
What is the brand name for cariprazine?
What is Vraylar? Vraylar (cariprazine) is an antipsychotic medication that affects chemicals in the brain. Vraylar is used to treat schizophrenia in adults. Vraylar is also used to treat manic or mixed episodes in adults with bipolar disorder type I.
What is another name for brexpiprazole?
Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic.
What are pharmaceutical companies?
Pharmaceutical companies invest lots of money to research and produce drugs/medicines for patients. These companies study the diseases, research, and invent new drugs/medicines for the diseases. Drug discovery and marketing are major expenses for these companies.
Is cariprazine available in India?
Vraylar Cariprazine
| Packaging Size | 30 capsules |
|---|---|
| Composition | Cariprazine |
| Treatment | schizophrenia and bipolar disorder |
| Form | capsules |
| Country of Origin | Made in India |
What makes Lundbeck different?
We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization. With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for brain diseases.
What is the current status of Lundbeck India Private Limited?
Lundbeck India Private Limited’s Corporate Identification Number is (CIN) U24231KA2002PTC029998 and its registration number is 29998.Its Email address is [email protected] and its registered address is ‘H M Towers’, I Floor # 58, Brigade Road Bengaluru Bangalore KA 560025 IN , – , . Current status of Lundbeck India Private Limited is – Active.
When did Lundbeck enter the pharmaceutical market?
Lundbeck entered the pharmaceutical market in 1924, importing medicines and cosmetics from companies based in other European and American countries. By the late 1930s, Lundbeck had begun to produce its own medicinal products and had established its own research department.
Why choose ledlundbeck?
Lundbeck has a broad range of products within brain diseases. With registered products in more than 100 countries, we leverage our global presence to bring innovative therapies to people living with brain diseases around the world.
